clodronic acid has been researched along with Agnogenic Myeloid Metaplasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, M; Horiuchi, T; Izumi, T; Kato, S; Kawamura, T; Kimura, F; Kobayashi, A; Kobayashi, S; Maekawa, T; Nagao, S; Okada, Y; Osawa, Y; Saga, R; Sato, K; Suzu, S; Tachi, N; Takano, K; Teramoto, M; Watanabe, J; Yamamura, T | 1 |
| Aghai, E; Braester, A; Elmalah, I; Froom, P; Quitt, M | 1 |
2 other study(ies) available for clodronic acid and Agnogenic Myeloid Metaplasia
| Article | Year |
|---|---|
Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis.
Topics: Animals; Bone Marrow; Cell Differentiation; Cell Line; Clodronic Acid; Fibroblasts; Hematopoietic Stem Cells; Humans; Immunohistochemistry; Janus Kinase 2; Macrophages; Mice; Monocytes; Phenotype; Primary Myelofibrosis; Receptors, Thrombopoietin; Signal Transduction; STAT Transcription Factors; Thrombopoietin | 2017 |
Clodronate in myelofibrosis: a case report.
Topics: Antimetabolites; Blood Transfusion; Bone Marrow Cells; Clodronic Acid; Humans; Male; Middle Aged; Primary Myelofibrosis | 2002 |